Peer review reports
From: Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus
Original Submission | ||
---|---|---|
17 Mar 2020 | Submitted | Original manuscript |
8 Apr 2020 | Reviewed | Reviewer Report |
20 Apr 2020 | Reviewed | Reviewer Report - Vinod Balasubramaniam |
21 May 2020 | Author responded | Author comments - Jie Yuan |
Resubmission - Version 2 | ||
21 May 2020 | Submitted | Manuscript version 2 |
30 May 2020 | Reviewed | Reviewer Report - Vinod Balasubramaniam |
5 Jun 2020 | Reviewed | Reviewer Report |
9 Jun 2020 | Author responded | Author comments - Jie Yuan |
Resubmission - Version 3 | ||
9 Jun 2020 | Submitted | Manuscript version 3 |
Publishing | ||
11 Jun 2020 | Editorially accepted | |
31 Jul 2020 | Article published | 10.1186/s12916-020-01663-1 |